Krónikus obstruktív tüdőbetegség (COPD): vizsgálatok itt: Ausztrália
14 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- 2. fázisTaking peoplePRA-216 COPD Safety and Biomarker Study
- Where
- Birtinya, Botany, Camberwell, Campbelltown, Southport
- Életkor
- 40 év to 80 év
- People
- 40
- Run by
- Prana Therapies Inc
See details and how to joinNCT07730281 - 2. fázisTaking peopleA Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Where
- Cairns, Nedlands, Norwood, Osborne Park, South Brisbane, Wollongong
- Életkor
- 40 év and over
- People
- 987 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07082738 - 3. fázisTaking peopleEfficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- Where
- Coffs Harbour, Dunedin, Osborne Park, South Brisbane, Tiwi, Townsville, Traralgon
- Életkor
- 40 év to 80 év
- People
- 942 worldwide
- Run by
- Sanofi
See details and how to joinNCT07190222 · EU 2024-518213-25-00 - 2/3. fázisTaking peopleA Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- Where
- Clayton, South Brisbane, Spearwood, Westmead
- Életkor
- 35 év to 80 év
- People
- 1156 worldwide
- Run by
- Pfizer
See details and how to joinNCT07363694 · EU 2024-518587-12-00 - 1/2. fázisTaking peopleA Study of the Safety, Tolerability, Pharmacokinetics and Efficacy of KIT2014 in Patients With Moderate to Severe COPD
- Where
- Camberwell, Charlestown, Sydney
- Életkor
- 40 év to 80 év
- People
- 36
- Run by
- Kither Biotech Srl
See details and how to joinNCT07668518 - 3. fázisTaking peopleA Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Where
- Coffs Harbour, Frankston, Garran, Nedlands, New Lambton, Spearwood, Wollongong, Woodville South
- Életkor
- 40 év to 80 év
- People
- 990 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06878261 · EU 2024-517457-27-00 - 3. fázisTaking peopleDepemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
- Where
- Coffs Harbour, Maroubra, Midland, Westmead
- Életkor
- 40 év to 80 év
- People
- 961 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT06961214 · EU 2024-520417-41-00 - 3. fázisTaking peopleA Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Where
- Birtinya, Cairns, Chermside, Coffs Harbour, Dubbo, Nedlands, Port Macquarie, Spearwood, St Albans, Waitara, Wangaratta
- Életkor
- 40 év to 80 év
- People
- 5250 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06283966 · EU 2023-507407-59-00 - No phaseTaking peopleAn Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
- Where
- Adelaide, Brisbane, Macquarie Park
- Életkor
- 40 év to 80 év
- People
- 200 worldwide
- Run by
- Pulmonx Corporation
See details and how to joinNCT06035120 - 1. fázisTaking peopleInhaled RB042 in Healthy Adult Volunteers, Healthy Adult Smokers and Patients With Chronic Obstructive Pulmonary Disease
- Where
- Nedlands
- Életkor
- 18 év to 80 év
- People
- 105
- Run by
- Atisama Therapeutics
See details and how to joinNCT07285122 - 1. fázisTaking peopleInvestigation of Small Mobile Stem Cells (SMS Cells) in Participants With Chronic Obstructive Pulmonary Disease (COPD).
- Where
- Melbourne
- Életkor
- 39 év to 69 év
- People
- 18
- Run by
- SMSbiotech
See details and how to joinNCT06986070 - 3. fázisTaking peopleeValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
- Where
- Coffs Harbour, Spearwood
- Életkor
- 40 év to 75 év
- People
- 1196 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT07177339 · EU 2025-521108-23-00 - 1. fázisTaking peopleA Study of BBT002 in Healthy Volunteers (HVs) and in Adult Patients With Chronic Obstructive Pulmonary Disease (COPD) or Chronic Rhiosininusitis With Nasal Polyps (CRSwNP)
- Where
- Brisbane, Perth
- Életkor
- 18 év to 80 év
- People
- 286 worldwide
- Run by
- Bambusa Therapeutics
See details and how to joinNCT06944925 · EU 2025-523142-28-00 - 3. fázisCsak meghívásosLong Term Safety of Alpha1-Proteinase Inhibitor in Subjects With Alpha1 Antitrypsin Deficiency
- Where
- Adelaide, Chermside, Darlinghurst, Fitzroy, Nedlands
- Életkor
- 20 év to 72 év
- People
- 290 worldwide
- Run by
- Grifols Therapeutics LLC
See details and how to joinNCT02796937